Patients may be referred for evaluation with Multiple Sclerosis or potential MS. Recent FDA-approved medications to reduce the risk of relapses make early diagnosis and treatment particularly important. Access to state-of-the-art neuroradiological and neurophysiological testing are available to assist in the diagnosis and treatment of MS. Experimental protocols may be offered where appropriate.